
MRC Funding Reopens for Curiosity-Driven Research as UK Medical Projects Gain New Momentum
MRC reopens curiosity-driven funding, creating new opportunities for UK medical researchers across fellowships, proof-of-concept and equipment schemes.
Major funding announcements, research programmes and investment in UK medical science.

MRC reopens curiosity-driven funding, creating new opportunities for UK medical researchers across fellowships, proof-of-concept and equipment schemes.

MRC invests £50 million in a new UK centre to study mitochondrial disease and develop future therapies.

MRC invests £50 million in a new UK centre to study mitochondrial diseases and develop future therapies.

UKRI’s MRC opens and closes key funding calls in September 2026 across clinical research, translation and equipment support.

MRC invests £50 million in mitochondrial disease research to drive new therapies and advance UK-led genetic medicine.

MRC has opened a £50 million funding round for UK health research tackling complex, interdisciplinary medical challenges.

UKRI’s MRC invests £50m in a new centre to advance mitochondrial disease research and develop future therapies.

UKRI and BHF invest £72 million in a new institute to study obesity, improve prevention and accelerate treatment research.

MRC invests £50 million in mitochondrial disease research to accelerate new therapies and advance UK science.

The UK MRC has launched a £50 million centre to advance mitochondrial disease therapies and rare disease research.